argenx · 4 hours ago
Senior Director, Safety Data and Systems
Maximize your interview chances
BiotechnologyClinical Trials
Insider Connection @argenx
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Collaborate with applicable GPS functional areas to evaluate opportunities for technology based process improvements
Partner with the Quality functions to ensure compliance with all applicable quality and validation standards
Represent GPS Safety Systems in interactions with applicable argenx functions (e.g. Quality, Regulatory, Data Management, Business Information Systems, Quantitative Science) in regards to pharmacovigilance technical roadmap, setup and operation
Provide expert technical and operational guidance to safety vendors and internal staff
Support GPS business owners of pharmacovigilance systems and assume the business owner role when designated, driving continuous system enhancement and operational support
Oversee and guide GPS collaboration with Safety vendor on safety database upgrades and major Safety database configuration changes
Direct the development and maintenance of safety database queries, safety analysis and tracking tools
Lead the development and implementation procedural documents such as SOPs and Work Instructions job aides and other documents and conventions as applicable
Maintain advanced expertise on applicable regulatory and PV tech guidelines and share with GPS team members as applicable
Get involved in additional task and projects as assigned by line manager or Head of GPS
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Advanced proficiency in Safety Database systems (Argus) and Safety Signalling systems (Empirica) as well as other technical systems applicable to Safety / Pharmacovigilance (e.g. E2B gateways)
Advanced working knowledge of relevant global pharmacovigilance regulatory requirements and guidance documents (including Europe, US, Japan)
Advanced computer skills in all current office applications including PowerPoint, Visio
Expert level skill in Excel usage required
Expertise in writing and validating SQL programming queries required
Robust proficiency in electronic systems commonly used for Clinical Research (e.g. EDC, TMF) and various data visualization and analysis tools, dashboards
Robust understanding of the quality management processes, metrics and KPIs
Advanced project management skills to complete multiple complex deliverables within tight timelines
Ability to communicate effectively and collaborate successfully across functions and with vendors
Fluent communication in written and spoken English required
Work independently with minimal oversight and prioritize effectively
Effectively function in a team environment
At least Bachelors’ degree (or country equivalent) in life sciences / Information technology or other relevant field required
Minimum of 15 years of relevant experience in IT / Safety / Clinical Research / Pharmacovigilance overall with 10 years or more of relevant experience in Safety database / signal management systems including the usage of advanced technology and tools used in the Safety / PV / Medical technology fields
Proven experience in PV/Safety Systems technical administration and support including coding and programming
Proven experience in safety data retrieval activities such as development and generation of custom aggregate listings
Equivalent and adequate combination of education and experience
Preferred
A well rounded mix of experience in CRO / Consulting / Pharma / Pre- and Post marketing Safety technology environment would be preferred
Management experience or experience in the oversight of functional teams would be a plus
Company
argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Funding
Current Stage
Public CompanyTotal Funding
$3.75BKey Investors
Forbion Capital Partners
2023-07-19Post Ipo Equity· $1.1B
2022-03-23Post Ipo Equity· $700M
2021-02-02Post Ipo Equity· $999.38M
Recent News
Morningstar, Inc.
2024-11-26
2024-11-25
GlobeNewswire News Room
2024-11-05
Company data provided by crunchbase